Erschienen in:
01.11.2007
Clinical Significance of Perioperative Immunonutrition for Patients with Esophageal Cancer
verfasst von:
Hiroya Takeuchi, Shunji Ikeuchi, Yoshiki Kawaguchi, Yuko Kitagawa, Yoh Isobe, Kiyoshi Kubochi, Masaki Kitajima, Sumio Matsumoto
Erschienen in:
World Journal of Surgery
|
Ausgabe 11/2007
Einloggen, um Zugang zu erhalten
Abstract
Background
We hypothesized that preoperative and/or postoperative enteral immune-enhanced formulas that are supplemented with arginine, omega-3 fatty acids, and RNA may reduce postoperative complications in patients undergoing esophagectomy for thoracic esophageal squamous cell carcinoma (ESCC).
Methods
Forty patients who underwent esophagectomy were divided into three groups: group A (n = 20) received a control enteral diet (Erental) through the jejunostomy after surgery. group B (n = 6) received an enteral diet supplemented with immune-enhancing substrates (Impact) containing arginine, omega-3 fatty acids, and RNA after surgery. group C (n = 14) received the impact before and after surgery.
Results
Lymphocyte counts in group C on postoperative day (POD) 7 were somewhat higher than that in group A (p = 0.07) and significantly higher than in group B (p = 0.03). Furthermore the incidence of incisional wound infection in group C was significantly lower than that in group A (p = 0.03). Moreover, the duration of postoperative systemic inflammatory response syndrome (SIRS) was significantly shorter in group C than in group A (p < 0.05).
Conclusions
This study reveals that the perioperative immune-enhanced formula may be superior to postoperative control enteral formulas in terms of reducing surgical wound infection and postoperative SIRS, which may result in serious postoperative complications for patients who have undergone esophagectomy.